Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VWO vs GSK✓SelectedUSD · GSKVWO vs GSK performance historyLatest closeAs of-2.05%11/19
Stock and ETF performance explorer

VWO vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+19.6%
GSK return
+39.6%
Excess return
-19.9%
Maximum drawdown
-29.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.0%-1.6%-0.5%-1.8%
7D-6.7%-4.7%-2.0%-6.0%
30D-9.6%-4.7%-4.9%-9.0%
3M-12.1%-8.8%-3.4%-10.9%
6M-8.7%-4.6%-4.1%-8.3%
YTD-1.7%+1.0%-2.7%-2.4%
1Y-0.1%+6.9%-7.0%-1.8%
3Y+41.9%+52.5%-10.7%+27.8%
5Y+19.6%+40.3%-20.6%+3.5%
All+19.6%+39.6%-19.9%+3.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling